Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic (164 views)
J Clin Med (ISSN: 2077-0383linking, 2077-0383electronic), 2020 Aug 3; 9(8): N/D-N/D.
Export to BibTeX Export to EndNote
Paper type: Journal Article, Review,
Impact factor: 6.78, 5-year impact factor: 0
Url: Not available.
Keywords: Cirrhosis, Gut Microbiota, Gut Virome, Hepatocellular Carcinoma, Steatosis,
Affiliations:
*** IBB - CNR ***
Internal Medicine Unit, "Madonna del Soccorso" General Hospital, San Benedetto del, 63074 Tronto, Italy.
Department of Biomedical Sciences, KU Leuven, Gasthuisberg University Hospital, TARGID, 3000 Leuven, Belgium.
Institute for Biostructure and Bioimaging, National Research Council, Molecular Biotechnology Center, 10121 Turin, Italy.
Nephrology and Urology Department, Gastroenterology, Endocrinology, Fondazione Policlinico A, Clinical Nutrition Unit, Gemelli IRCCS, 00168 Rome, Italy.
Institute of Medical Pathology, Catholic University of the Sacred Heart, 00168 Rome, Italy.
Institute of Legal Medicine and Department of Surgical and Medical Sciences, University "Magna Graecia" of Catanzaro (UMG), 88100 Viale Europa, Italy.
Department of Health Sciences, University "Magna Græcia", 88100 Catanzaro, Italy.
References:
Not available.
J Clin Med (ISSN: 2077-0383linking, 2077-0383electronic), 2020 Aug 3; 9(8): N/D-N/D.
Export to BibTeX Export to EndNote
Paper type: Journal Article, Review,
Impact factor: 6.78, 5-year impact factor: 0
Url: Not available.
Keywords: Cirrhosis, Gut Microbiota, Gut Virome, Hepatocellular Carcinoma, Steatosis,
Affiliations:
*** IBB - CNR ***
Internal Medicine Unit, "Madonna del Soccorso" General Hospital, San Benedetto del, 63074 Tronto, Italy.
Department of Biomedical Sciences, KU Leuven, Gasthuisberg University Hospital, TARGID, 3000 Leuven, Belgium.
Institute for Biostructure and Bioimaging, National Research Council, Molecular Biotechnology Center, 10121 Turin, Italy.
Nephrology and Urology Department, Gastroenterology, Endocrinology, Fondazione Policlinico A, Clinical Nutrition Unit, Gemelli IRCCS, 00168 Rome, Italy.
Institute of Medical Pathology, Catholic University of the Sacred Heart, 00168 Rome, Italy.
Institute of Legal Medicine and Department of Surgical and Medical Sciences, University "Magna Graecia" of Catanzaro (UMG), 88100 Viale Europa, Italy.
Department of Health Sciences, University "Magna Græcia", 88100 Catanzaro, Italy.
References:
Not available.
Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic
BACKGROUND AND AIMS: The gut microbiota is a complex ecosystem containing bacteria, viruses, fungi, yeasts and other single-celled organisms. It is involved in the development and maintenance of both innate and systemic immunity of the body. Emerging evidence has shown its role in liver diseases through the immune system cross-talk. We review herein literature data regarding the triangular interaction between gut microbiota, immune system and liver in health and disease. METHODS: We conducted a search on the main medical databases for original articles, reviews, meta-analyses, randomized clinical trials and case series using the following keywords and acronyms and their associations: gut microbiota, microbiome, gut virome, immunity, gastrointestinal-associated lymphoid tissue (GALT), non-alcoholic fatty liver disease (NAFLD), non-alcoholic steato-hepatitis (NASH), alcoholic liver disease, liver cirrhosis, hepatocellular carcinoma. RESULTS: The gut microbiota consists of microorganisms that educate our systemic immunity through GALT and non-GALT interactions. The latter maintain health but are also involved in the pathophysiology and in the outcome of several liver diseases, particularly those with metabolic, toxic or immune-mediated etiology. In this context, gut virome has an emerging role in liver diseases and needs to be further investigated, especially due to the link reported between severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection and hepatic dysfunctions. CONCLUSIONS: Changes in gut microbiota composition and alterations in the immune system response are involved in the pathogenesis of metabolic and immune-mediated liver diseases.
BACKGROUND AND AIMS: The gut microbiota is a complex ecosystem containing bacteria, viruses, fungi, yeasts and other single-celled organisms. It is involved in the development and maintenance of both innate and systemic immunity of the body. Emerging evidence has shown its role in liver diseases through the immune system cross-talk. We review herein literature data regarding the triangular interaction between gut microbiota, immune system and liver in health and disease. METHODS: We conducted a search on the main medical databases for original articles, reviews, meta-analyses, randomized clinical trials and case series using the following keywords and acronyms and their associations: gut microbiota, microbiome, gut virome, immunity, gastrointestinal-associated lymphoid tissue (GALT), non-alcoholic fatty liver disease (NAFLD), non-alcoholic steato-hepatitis (NASH), alcoholic liver disease, liver cirrhosis, hepatocellular carcinoma. RESULTS: The gut microbiota consists of microorganisms that educate our systemic immunity through GALT and non-GALT interactions. The latter maintain health but are also involved in the pathophysiology and in the outcome of several liver diseases, particularly those with metabolic, toxic or immune-mediated etiology. In this context, gut virome has an emerging role in liver diseases and needs to be further investigated, especially due to the link reported between severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection and hepatic dysfunctions. CONCLUSIONS: Changes in gut microbiota composition and alterations in the immune system response are involved in the pathogenesis of metabolic and immune-mediated liver diseases.
Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic
No results. |
Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic
Other filter: ([btitle,keywords] "Gut Microbiota" OR [ ...
Ahmad F, Saha P, Singh V, Wahid M, Mandal RK, Nath Mishra B, Fagoonee S, Haque S
* Diet as a modifiable factor in tumorigenesis: Focus on microbiome-derived bile acid metabolites and short-chain fatty acids (155 views)
Food Chem (ISSN: 0308-8146linking), 2023 Jun 1; 410: 135320-135320.
Impact Factor:
View Export to BibTeX Export to EndNote
Ribaldone DG, Pellicano R, Fagoonee S, Actis GC
* Modulation of the gut microbiota: opportunities and regulatory aspects (79 views)
Minerva Gastroenterol (ISSN: 2724-5985linking), 2023 Mar; 69 (1 ): 128-140.
Impact Factor:
View Export to BibTeX Export to EndNote
Ricci A, Roviello GN
Exploring the Protective Effect of Food Drugs against Viral Diseases: Interaction of Functional Food Ingredients and SARS-CoV-2, Influenza Virus, and HSV (159 views)
Life, 2023 Feb; 13: 402-417.
Impact Factor: 3.2
View Export to BibTeX Export to EndNote
Guzzardi MA, La Rosa F, Campani D, Collado MC, Monleon D, Cacciato Insilla A, Tripodi M, Zega A, Dattilo A, Brunetto MR, Maffei M, Bonino F, Iozzo P
* Liver and White/Brown Fat Dystrophy Associates with Gut Microbiota and Metabolomic Alterations in 3xTg Alzheimer’s Disease Mouse Model (38 views)
Metabolites (ISSN: 2218-1989electronic), 2022 Mar 22; 12 (4 ): N/D-N/D.
Impact Factor:
View Export to BibTeX Export to EndNote
Guzzardi MA, La Rosa F, Campani D, Cacciato Insilla A, De Sena V, Panetta D, Brunetto MR, Bonino F, Collado MC, Iozzo P
* Maturation of the Visceral (Gut-Adipose-Liver) Network in Response to the Weaning Reaction versus Adult Age and Impact of Maternal High-Fat Diet (137 views)
Nutrients (ISSN: 2072-6643linking, 2072-6643electronic), 2021 Sep 28; 13 (10 ): N/D-N/D.
Impact Factor: 4.171
View Export to BibTeX Export to EndNote
Caputo T, Cusano AM, Ruvo M, Aliberti A, Cusano A
* Human Serum Albumin Nanoparticles as a Carrier for On-Demand Sorafenib Delivery (226 views)
Curr Pharm Biotechnol (ISSN: 1389-2010linking), 2021 Aug 26; N/D: N/D-N/D.
Impact Factor: 2.097
View Export to BibTeX Export to EndNote
Moldovan DC, Ismaiel A, Fagoonee S, Pellicano R, Abenavoli L, Dumitrascu DL
* Gut microbiota and cardiovascular diseases axis: a review (91 views)
Hepatology (ISSN: 0026-4806linking, 1827-1669electronic), 2021 May 10; N/D: N/D-N/D.
Impact Factor: 1.202
View Export to BibTeX Export to EndNote
Gaia S, Ciruolo M, Ribaldone DG, Rolle E, Migliore E, Mosso E, Vola S, Risso A, Fagoonee S, Saracco GM, Carucci P
* Higher Efficiency of Percutaneous Microwave (MWA) Than Radiofrequency Ablation (RFA) in Achieving Complete Response in Cirrhotic Patients with Early Hepatocellular Carcinoma (88 views)
Curr Oncol (ISSN: 1718-7729electronic, 1198-0052linking), 2021 Feb 25; 28(2): 1034-1044.
Impact Factor: 2.048
View Export to BibTeX Export to EndNote
Ricco G, Cosma C, Bedogni G, Biasiolo A, Guarino M, Pontisso P, Morisco F, Oliveri F, Cavallone D, Bonino F, Plebani M, Brunetto MR
* Modeling the time-related fluctuations of AFP and PIVKA-II serum levels in patients with cirrhosis undergoing surveillance for hepatocellular carcinoma (69 views)
Cancer Biomark (ISSN: 1574-0153linking), 2020; 29(2): 189-196.
Impact Factor: 3.436
View Export to BibTeX Export to EndNote
Testino G, Leone S, Fagoonee S
* Hepatitis C virus, alcohol use disorders and hepatocellular carcinoma (218 views)
Panminerva Med (ISSN: 1827-1898electronic, 0031-0808linking), 2018 Jul 10; N/D: N/D-N/D.
Impact Factor: 1.957
View Export to BibTeX Export to EndNote
Caviglia GP, Fagoonee S
* Role and function of exosomal miR-9-3p in hepatocellular carcinoma (275 views)
Hepatology (ISSN: 1827-1669electronic, 0026-4806linking), 2018 Feb; 109(1): 4-6.
Impact Factor: 0.913
View Export to BibTeX Export to EndNote
Ricco G, Cavallone D, Cosma C, Caviglia GP, Oliveri F, Biasiolo A, Abate ML, Plebani M, Smedile A, Bonino F, Pontisso P, Brunetto MR
* Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers (691 views)
Cancer Biomark (ISSN: 1574-0153, 1574-0153linking), 2017 Dec 15; 21(3): 603-612.
Impact Factor: 2.392
View Export to BibTeX Export to EndNote
Imbriaco M, De LucaS, Coppola M, Fusari M, Klain M, Puglia M, Mainenti P, Liuzzi R, Maurea S
* Diagnostic Accuracy of Gd-EOB-DTPA for Detection Hepatocellular Carcinoma (HCC): A Comparative Study with Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) and Dynamic Contrast Enhanced Computed Tomography (CT) (334 views)
Pol J Radiol (ISSN: 1733-134xprint, 1733-134xlinking, 1899-0967electronic), 2017 Feb 01; 82: 50-57.
Impact Factor: 0.567
View Export to BibTeX Export to EndNote
Pelagalli A, Nardelli A, Fontanella R, Zannetti A
* Inhibition of AQP1 Hampers Osteosarcoma and Hepatocellular Carcinoma Progression Mediated by Bone Marrow-Derived Mesenchymal Stem Cells (477 views) (PDF 328 views)
Int J Mol Sc (ISSN: 1422-0067, 1661-6596, 1422-0067linking), 2016 Jul 11; 17(7): N/D-N/D.
Impact Factor: 4.556
View Export to BibTeX Export to EndNote
Fontanella R, Pelagalli A, Nardelli A, D'Alterio C, Ierano C, Cerchia L, Lucarelli E, Scala S, Zannetti A
* A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion (1068 views) (PDF 305 views)
Cancer Lett (ISSN: 0304-3835), 2015 Oct 27; 370(1): 100-107.
Impact Factor: 7.36
View Export to BibTeX Export to EndNote
Erra P, Puglia M, Ragozzino A, Maurea S, Liuzzi R, Sabino G, Barbuto L, Cuocolo A, Imbriaco M
* Appearance of hepatocellular carcinoma on gadoxetic acid-enhanced hepato-biliary phase MR imaging: a systematic review (378 views)
Radiol Med (ISSN: 0033-8362, 1826-6983, 0033-8362linking), 2015 Apr 22; 120(11): 1002-1011.
Impact Factor: 1.523
View Export to BibTeX Export to EndNote
Neve Polimeno M, Ierano C, D'Alterio C, Simona Losito N, Napolitano M, Portella L, Scognamiglio G, Tatangelo F, Maria Trotta A, Curley S, Costantini S, Liuzzi R, Izzo F, Scala S
* CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not (800 views)
Cell Mol Immunol (ISSN: 1672-7681), 2014 Nov 3; 12(4): 474-482.
Impact Factor: 4.112
View Export to BibTeX Export to EndNote
Di Lorenzo G, Imbimbo M, Leopardo D, Marciano R, Federico P, Buonerba C, Salvatore B, Marinelli A, Palmieri G. A
* A long-lasting response to sorafenib treatment in an advanced hepatocellular carcinoma patient (436 views)
Int J Immunopathol Pharmacol (ISSN: 0394-6320), 2010 Jul; 23(3): 951-954.
Impact Factor: 2.685
View Export to BibTeX Export to EndNote
Morante A, Romano M, Cuomo A, De Sio I, Cozzolino A, Mucherino C, Salerno R, Blanco C, Romano M
* Massive gastric ulceration after transarterial chemoembolization for hepatocellular carcinoma (209 views)
Gastrointestinal Endoscopy (ISSN: 0016-5107), 2006 Apr; 63(4): 718-720.
Impact Factor: 4.825
View Export to BibTeX Export to EndNote
Sirignano C, Soscia E, Mainenti PP, Camera L, Salvatore M
* Tumor Thrombus In The Right Atrium And In The Inferior Vena Cava As Primary Clinical Manifestations Of Hepatocellular Carcinoma. A Case Report (431 views)
42 Congresso Nazionale Sirm Milano, 2006; N/D: 1-3.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Romano M, Giojelli A, Tamburrini O, Salvatore M
* Chemoembolization for hepatocellular carcinoma: Effect of intraarterial lidocaine in peri- and post-procedural pain and hospitalization (558 views)
Radiol Med (ISSN: 0033-8362, 1826-6983, 1826-6983electronic), 2003 Apr; 105(4): 350-355.
Impact Factor: 1.368
View Export to BibTeX Export to EndNote
* Diet as a modifiable factor in tumorigenesis: Focus on microbiome-derived bile acid metabolites and short-chain fatty acids (155 views)
Food Chem (ISSN: 0308-8146linking), 2023 Jun 1; 410: 135320-135320.
Impact Factor:
View Export to BibTeX Export to EndNote
Ribaldone DG, Pellicano R, Fagoonee S, Actis GC
* Modulation of the gut microbiota: opportunities and regulatory aspects (79 views)
Minerva Gastroenterol (ISSN: 2724-5985linking), 2023 Mar; 69 (1 ): 128-140.
Impact Factor:
View Export to BibTeX Export to EndNote
Ricci A, Roviello GN
Exploring the Protective Effect of Food Drugs against Viral Diseases: Interaction of Functional Food Ingredients and SARS-CoV-2, Influenza Virus, and HSV (159 views)
Life, 2023 Feb; 13: 402-417.
Impact Factor: 3.2
View Export to BibTeX Export to EndNote
Guzzardi MA, La Rosa F, Campani D, Collado MC, Monleon D, Cacciato Insilla A, Tripodi M, Zega A, Dattilo A, Brunetto MR, Maffei M, Bonino F, Iozzo P
* Liver and White/Brown Fat Dystrophy Associates with Gut Microbiota and Metabolomic Alterations in 3xTg Alzheimer’s Disease Mouse Model (38 views)
Metabolites (ISSN: 2218-1989electronic), 2022 Mar 22; 12 (4 ): N/D-N/D.
Impact Factor:
View Export to BibTeX Export to EndNote
Guzzardi MA, La Rosa F, Campani D, Cacciato Insilla A, De Sena V, Panetta D, Brunetto MR, Bonino F, Collado MC, Iozzo P
* Maturation of the Visceral (Gut-Adipose-Liver) Network in Response to the Weaning Reaction versus Adult Age and Impact of Maternal High-Fat Diet (137 views)
Nutrients (ISSN: 2072-6643linking, 2072-6643electronic), 2021 Sep 28; 13 (10 ): N/D-N/D.
Impact Factor: 4.171
View Export to BibTeX Export to EndNote
Caputo T, Cusano AM, Ruvo M, Aliberti A, Cusano A
* Human Serum Albumin Nanoparticles as a Carrier for On-Demand Sorafenib Delivery (226 views)
Curr Pharm Biotechnol (ISSN: 1389-2010linking), 2021 Aug 26; N/D: N/D-N/D.
Impact Factor: 2.097
View Export to BibTeX Export to EndNote
Moldovan DC, Ismaiel A, Fagoonee S, Pellicano R, Abenavoli L, Dumitrascu DL
* Gut microbiota and cardiovascular diseases axis: a review (91 views)
Hepatology (ISSN: 0026-4806linking, 1827-1669electronic), 2021 May 10; N/D: N/D-N/D.
Impact Factor: 1.202
View Export to BibTeX Export to EndNote
Gaia S, Ciruolo M, Ribaldone DG, Rolle E, Migliore E, Mosso E, Vola S, Risso A, Fagoonee S, Saracco GM, Carucci P
* Higher Efficiency of Percutaneous Microwave (MWA) Than Radiofrequency Ablation (RFA) in Achieving Complete Response in Cirrhotic Patients with Early Hepatocellular Carcinoma (88 views)
Curr Oncol (ISSN: 1718-7729electronic, 1198-0052linking), 2021 Feb 25; 28(2): 1034-1044.
Impact Factor: 2.048
View Export to BibTeX Export to EndNote
Ricco G, Cosma C, Bedogni G, Biasiolo A, Guarino M, Pontisso P, Morisco F, Oliveri F, Cavallone D, Bonino F, Plebani M, Brunetto MR
* Modeling the time-related fluctuations of AFP and PIVKA-II serum levels in patients with cirrhosis undergoing surveillance for hepatocellular carcinoma (69 views)
Cancer Biomark (ISSN: 1574-0153linking), 2020; 29(2): 189-196.
Impact Factor: 3.436
View Export to BibTeX Export to EndNote
Testino G, Leone S, Fagoonee S
* Hepatitis C virus, alcohol use disorders and hepatocellular carcinoma (218 views)
Panminerva Med (ISSN: 1827-1898electronic, 0031-0808linking), 2018 Jul 10; N/D: N/D-N/D.
Impact Factor: 1.957
View Export to BibTeX Export to EndNote
Caviglia GP, Fagoonee S
* Role and function of exosomal miR-9-3p in hepatocellular carcinoma (275 views)
Hepatology (ISSN: 1827-1669electronic, 0026-4806linking), 2018 Feb; 109(1): 4-6.
Impact Factor: 0.913
View Export to BibTeX Export to EndNote
Ricco G, Cavallone D, Cosma C, Caviglia GP, Oliveri F, Biasiolo A, Abate ML, Plebani M, Smedile A, Bonino F, Pontisso P, Brunetto MR
* Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers (691 views)
Cancer Biomark (ISSN: 1574-0153, 1574-0153linking), 2017 Dec 15; 21(3): 603-612.
Impact Factor: 2.392
View Export to BibTeX Export to EndNote
Imbriaco M, De LucaS, Coppola M, Fusari M, Klain M, Puglia M, Mainenti P, Liuzzi R, Maurea S
* Diagnostic Accuracy of Gd-EOB-DTPA for Detection Hepatocellular Carcinoma (HCC): A Comparative Study with Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) and Dynamic Contrast Enhanced Computed Tomography (CT) (334 views)
Pol J Radiol (ISSN: 1733-134xprint, 1733-134xlinking, 1899-0967electronic), 2017 Feb 01; 82: 50-57.
Impact Factor: 0.567
View Export to BibTeX Export to EndNote
Pelagalli A, Nardelli A, Fontanella R, Zannetti A
* Inhibition of AQP1 Hampers Osteosarcoma and Hepatocellular Carcinoma Progression Mediated by Bone Marrow-Derived Mesenchymal Stem Cells (477 views) (PDF 328 views)
Int J Mol Sc (ISSN: 1422-0067, 1661-6596, 1422-0067linking), 2016 Jul 11; 17(7): N/D-N/D.
Impact Factor: 4.556
View Export to BibTeX Export to EndNote
Fontanella R, Pelagalli A, Nardelli A, D'Alterio C, Ierano C, Cerchia L, Lucarelli E, Scala S, Zannetti A
* A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion (1068 views) (PDF 305 views)
Cancer Lett (ISSN: 0304-3835), 2015 Oct 27; 370(1): 100-107.
Impact Factor: 7.36
View Export to BibTeX Export to EndNote
Erra P, Puglia M, Ragozzino A, Maurea S, Liuzzi R, Sabino G, Barbuto L, Cuocolo A, Imbriaco M
* Appearance of hepatocellular carcinoma on gadoxetic acid-enhanced hepato-biliary phase MR imaging: a systematic review (378 views)
Radiol Med (ISSN: 0033-8362, 1826-6983, 0033-8362linking), 2015 Apr 22; 120(11): 1002-1011.
Impact Factor: 1.523
View Export to BibTeX Export to EndNote
Neve Polimeno M, Ierano C, D'Alterio C, Simona Losito N, Napolitano M, Portella L, Scognamiglio G, Tatangelo F, Maria Trotta A, Curley S, Costantini S, Liuzzi R, Izzo F, Scala S
* CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not (800 views)
Cell Mol Immunol (ISSN: 1672-7681), 2014 Nov 3; 12(4): 474-482.
Impact Factor: 4.112
View Export to BibTeX Export to EndNote
Di Lorenzo G, Imbimbo M, Leopardo D, Marciano R, Federico P, Buonerba C, Salvatore B, Marinelli A, Palmieri G. A
* A long-lasting response to sorafenib treatment in an advanced hepatocellular carcinoma patient (436 views)
Int J Immunopathol Pharmacol (ISSN: 0394-6320), 2010 Jul; 23(3): 951-954.
Impact Factor: 2.685
View Export to BibTeX Export to EndNote
Morante A, Romano M, Cuomo A, De Sio I, Cozzolino A, Mucherino C, Salerno R, Blanco C, Romano M
* Massive gastric ulceration after transarterial chemoembolization for hepatocellular carcinoma (209 views)
Gastrointestinal Endoscopy (ISSN: 0016-5107), 2006 Apr; 63(4): 718-720.
Impact Factor: 4.825
View Export to BibTeX Export to EndNote
Sirignano C, Soscia E, Mainenti PP, Camera L, Salvatore M
* Tumor Thrombus In The Right Atrium And In The Inferior Vena Cava As Primary Clinical Manifestations Of Hepatocellular Carcinoma. A Case Report (431 views)
42 Congresso Nazionale Sirm Milano, 2006; N/D: 1-3.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Romano M, Giojelli A, Tamburrini O, Salvatore M
* Chemoembolization for hepatocellular carcinoma: Effect of intraarterial lidocaine in peri- and post-procedural pain and hospitalization (558 views)
Radiol Med (ISSN: 0033-8362, 1826-6983, 1826-6983electronic), 2003 Apr; 105(4): 350-355.
Impact Factor: 1.368
View Export to BibTeX Export to EndNote
21 Records (21 excluding Abstracts).
Total impact factor: 48.412 (48.412 excluding Abstracts).
Total 5 year impact factor: 40.503 (40.503 excluding Abstracts).
Total impact factor: 48.412 (48.412 excluding Abstracts).
Total 5 year impact factor: 40.503 (40.503 excluding Abstracts).
164 views. Last view on Saturday 01 June 2024, 8:30:34
ibb.cnr.it
